Age-associated epigenetic modifications in human DNA increase its








































Chronic inflammation and increased self reactivity are 
the hallmarks of aging and are thought to be the 
underlying cause of the many age-associated diseases 
such as Alzheimer’s; Rheumatoid Arthritis [1]. The 
mechanisms responsible are not well understood. It is 
well established that the immune system undergoes 
significant alterations with age. The consequences of 
progressive aging of the immune system include an 
increase in autoimmune phenomena, incidence of 
cancer, chronic inflammation, and predisposition to 
infections [2-5]. This suggests a decrease in the 
protective immune responses to exogenous and 
infectious agents, and an increase in reactivity to self or 








































ponsible for the increased reactivity to self, including 
loss of immune tolerance, and progressive age-
associated loss of tissue integrity yielding new self-
antigens. Another possibility is that advancing age leads 
to modifications in existing self-antigens [3, 4, 6] 
rendering them more immunogenic.  
 
Human DNA is an example of self-antigen that 
undergoes age-associated genetic and epigenetic altera-
tions [7-11]. It is well documented that aging cells 
subtly change their patterns of DNA methylation. 
Overall, cells and tissues become hypomethylated while 
selected genes become progressively hypermethylated 
and, potentially, permanently silenced [12, 13]. This is 
believed to be poor prognosis for malignancies [14, 15]. 
A large body of experimental evidence also supports the 


















Abstract:  Chronic  inflammation,  increased  reactivity  to  self‐antigens  and  incidences  of  cancer  are  hallmarks  of  aging.




cells.  We  observed  increased  upregulation  of  costimulatory  molecules  as  well  as  enhanced  secretion  of  IFN‐α  from
dendritic cells in response to DNA from aged donors as compared to DNA from young donors when it was delivered
intracellularly  via  Lipofectamine.  Investigations  into  the  mechanisms  revealed  that  DNA  from  aged  subjects  is  not
degraded, neither is it more damaged compared to DNA from young subjects. However, there is significantly decreased
global level of methylation suggesting that age‐associated hypomethylation of the DNA may be the cause of its increased
immunogenicity.  Increased  immunogenicity  of  self  DNA  may  thus  be  another  mechanism  that  may  contribute  to  the
increase in age‐associated chronic inflammation, autoimmunity and cancer. 
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DNA damage and aging [10]. DNA repair functions are 
severely compromised with age leading to DNA lesions 
with single and double stranded breaks [15, 16]. 
Moreover, free radicals and reactive oxygen species 
cause further damage to the DNA and oxidative DNA 
damage has been implicated in carcinogenesis, ageing 
[10,11,17] and several age-related degenerative diseases 
[18]. More recently Rodier et al. [19] have shown that 
persistent DNA damage in senescent cells induces pro-
inflammatory cytokine secretion. It is thus clear that 
aging leads to alterations in DNA that are implicated in 
various age-related disorders. 
 
In the present study, we have determined if the age-
associated alterations in DNA also affect its 
immunogenicity. We have tested our hypothesis using a 
previously established system [20] whereby we deliver 





DNA from aged subjects is more immunogenic than 
DNA from young subjects 
 
Human DNA is generally inert and does not stimulate 
dendritic cells (DCs). However, recent studies from 
our laboratory [20] as well as from others [21-23] 
suggest that DNA can activate DCs if delivered in 
vitro inside the cell through either transfection or via 
immune complexes. In vitro delivery of DNA mimics 
the normal physiological conditions where human 
DNA gains entry into the cells as complexed with 
proteins or cell debris from dying cells or immune 
complexes.  Therefore, to investigate our hypothesis, 
DNA extracted from the blood of aged and young 
subjects was delivered inside human monocyte derived 
DCs from healthy young donors using the transfection 
reagent lipofectamine. The concentration of DNA used 
was 1 μg/ml. This was found to be the optimal 
concentration from our previous studies [20] since 
higher concentrations were toxic while lower 
concentrations led to insufficient activation of DCs.     
Delivery of DNA led to the activation of DCs as 
evidenced by upregulation of costimulatory markers 
CD80 and CD86 (Figure 1A and B) and secretion of 
cytokines IFN-α (Figure 1C). A significantly increased 
upregulation of CD80 (p=0.008)   and CD86 (p=0.02) 
was observed in aged DNA (data is of 15 separate 
aged and young DNA) stimulated DCs compared to 
DCs stimulated with young DNA (Figure 1A and B). 
The maturation marker CD83 was not significantly 
upregulated (p=0.29) in either group.  Cytokine profile 
shows that there was significantly increased (p=0.003) 
secretion of IFN-α (data is of 30 separate aged and 
young DNA, Figure1C) by aged DNA-treated DCs as 
compared to young DNA-treated DCs. Introduction of 
lipofectamine alone did not activate DCs. Stimulatory 
activity of the DNA was lost when delivered without 
lipofectamine suggesting that exposure to DNA alone 
does not induce activation of DCs and that this 
requires its intracellular delivery. These data suggest 
that aging leads to alterations in DNA that enhance its 
immunogenicity, and may contribute to age-associated 
chronic inflammation and autoimmune phenomenon. 
 
DNA from aged subjects is demethylated compared 
to DNA from young subjects 
 
Next, we investigated the age-associated alterations in 
the DNA that may be responsible for its increased 
immunogenicity. Aging is associated with increased 
apoptosis [24], which may result in shorter fragments of 
DNA. Running the DNA on gel showed that the size of 
DNA obtained from both aged and young subjects was 
comparable (Figure 2A). Accumulation of DNA 
damage due to either oxidation or inefficient DNA 
repair mechanism is another characteristic of advancing 
age [15, 16, 25]. Therefore, we compared the DNA 
damage between aged and young DNA [damage of 25 
separate aged and young DNA was determined] by 
measuring the number of abasic sites by ELISA. Indeed, 
we observed an increase in DNA damage in the DNA 
from aged subjects relative to DNA from young; 
however, the difference was not significant (p=0.27, 
Figure 2B). Age-associated changes in DNA 
methylation patterns are also a hallmark of aging [8-10, 
26-29]; both an increase and a decrease DNA 
methylation have been reported [10, 29]. To determine 
if modifications in methylation are responsible for the 
immunogenicity of aged DNA, we compared the 
methylation level of
  the DNA from aged and young 
subjects using the global DNA methylation ELISA kit 
(methylation levels of 24 separate aged and young DNA 
were determined).  In this kit the methylated fraction of 
DNA is recognized by 5-methylcytosine antibody and 
quantified through an ELISA-like reaction. There was 
an approximately ten percent decrease (p=0.001) of 
DNA methylation in aged as compared to the DNA 
from young (Figure 2C). This suggests that DNA from 
aged is hypomethylated, which may result in enhancing 
its immunogenicity.  
  
Immunogenicity of mammalian DNA correlates 
inversely with DNA methylation 
 
To further confirm if hypomethylation  of aged DNA 
influences
 the immunogenicity of the DNA, we in vitro 
methylated the DNA from aged subjects using a methyl  
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correlated with time with increased methylation being 
observed at 18h compared to 4h of the reaction (Figure 
3A).  The experiment was repeated with five separate 
DNAs. In two experiments commercially obtained 
DNA from Jurkat and Hela cell lines were used for 
methylation. This was done to confirm that the results 















































Furthermore, intracellular delivery of this methylated 
DNA into DCs resulted in decrease in IFN-α secretion 
compared to untreated DNA control (Figure 3B). The 
decrease in IFN-α production correlated with increase 
in DNA methylation. These data clearly demonstrate 
that epigenetic changes in the DNA from aged subjects’ 
leads to decreased DNA methylation resulting in an 
enhanced immunogenicity of the DNA.  


























































































Since our results demonstrated a small but insignificant 
increased damage in the DNA from aged, we 
investigated if this damage also affected the 
immunogenicity of the DNA.  PBMCs from young 
subjects were exposed to hyderogen peroxide to induce 
DNA damage. This treatment led to an increased DNA 
damage as shown in figure 3C; however, intracellular 
delivery of this damaged DNA into DCs did not result 
in increased activation compared to undamaged DNA 
from the same individual (Figure 3D). This suggests 
that DNA damage does not alter its immunogenicity 
further confirming that hypomethylation of the DNA is 




Decreases in global level of methylation along with a 
concomitant increase in promoter methylation are the 












































These age-associated epigenetic changes are thought to 
play a key role in the development of cancer and 
autoimmune phenomena through modification of gene 
expression. Causes for age-related methylation changes 
remain unknown. 
 
Accumulating studies have indicated a potential role of 
DNA
  hypomethylation in the pathogenesis of 
autoimmune diseases [30-36]. Earlier in vivo studies 
have shown potentiation of autoimmunity in mice 
treated with hypomethylating agents such as
  5-
azacytidine, procainamide and hydralazine [31, 34]. 
Others studies described that DNA hypomethylation is 
essential for apoptotic DNA to induce
  SLE-like 
autoimmune disease in non-susceptible mice [35]. 
Changes in human DNA methylation patterns are also 
an important feature of cancer development and 
progression [14, 33, 36, 37]. Alterations of DNA 
methylation are one of the most consistent
 epigenetic 
   
www.impactaging.com                    96                                       AGING, February 2010, Vol.2 No.2changes in human cancers [37]. Human cancers 
generally
  show global DNA hypomethylation 
accompanied by region-specific
  hypermethylation a 
pattern similar to aging. Studies have shown hypo-
methylation of squamous cell carcinomas in White men 
was associated with shorter survival from the disease 
[38].  A potential role of DNA hypomethylation in other 
conditions such as atherosclerosis and autoimmune 
diseases [e.g., multiple sclerosis and lupus] is also being 
recognized [39, 40].  
 
As is evident abnormal DNA methylation plays a very 
important role in various pathologic states, such as 
leukemia and autoimmunity. The underlying mechanisms 
are however not fully delineated so far. Our data suggests 
that along with regulating the transcription of various 
genes these methylation changes also render the DNA to 
be more immunogenic. The immune system is normally 




































due to the rapid engulfment of apoptotic cells, and the 
abundance of extra- and intracellular DNases [41, 42]. 
However, phagocytic cells may be exposed to cellular 
DNA following tissue necrosis, inflammation, or viral 
infection. Defective clearance of apoptotic cells would 
also result in an accumulation of late phase apoptotic 
cells. Previous study from our laboratory in humans 
[43] and a recent study [44] in mice suggest that 
apoptotic cell clearance is decreased with age. This may 
result in release of DNA from apoptotic cells due to 
secondary necrosis. Such DNA in aging would be much 
more immunogenic since it is hypomethylated and 
would lead to maturation of dendritic cells and 
increased reactivity to self resulting in slow loss of 
peripheral self tolerance. The increased immunogenicity 
of hypomethylated DNA may thus be one of the 
mechanisms that contribute to the development of 
autoreactivity, cancer and chronic inflammation as-
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identification of the receptor and signaling pathways 
involved in the recognition of this hypomethylated 
DNA. Earlier studies with intracellular DNA delivered 
via transfection reagents have shown that DNA signals 
through non-TLR receptors [21-23]. Our own study [20] 
also found that the DNA was localized in the cytosol 
and was not accessible to intracellular TLRs in the 
endosomes. The nucleic acid sensing TLR3 and TLR8 
are found in the endosomes [45]. The two other known 
nucleic acid sensing TLRs, TLRs 7 and 9 are not 
expressed in human monocyte derived DCs and are also 
present in the endosomes [46]. Identification of the 
receptor would also provide novel target for therapy of 
autoimmune diseases.  
 
MATERIALS AND METHOD 
 
Blood donors. Blood was collected from healthy elderly 
(age 65-90 years) and young volunteer (age 20-35 
years) donors. Elderly subjects belong to middle-class 
socio-economic status and are living independently. A 
week prior to the study, they were asked to discontinue 
any vitamins, minerals and antioxidants that they may 
have been taking. The Institutional Review Board of the 
University of California, Irvine, approved this study. 
 
Preparation of human monocyte derived dendritic cells. 
DCs were prepared essentially as described [43]. 
Briefly, peripheral blood mononuclear cells (PBMCs) 
were separated by Ficoll-Hypaque density gradient 
centrifugation. Monocytes were purified from the 
PBMCs by positive
  selection with anti-CD14 
microbeads (Stemcell Sep, Vancouver, BC). The purity 
of the isolated
  CD14
+ monocytes was >90% as 
determined by flow cytometry.
 For the induction of DC 
differentiation, purified CD14
+ monocytes were cultured 
in a humidified atmosphere of 5%
 CO2 at 37°C in RPMI 
1640 supplemented with10%FBS, 1 mM
 glutamine, 100 
U/ml penicillin, 100 µg/ml streptomycin,
  50 ng/ml 
human rGM-CSF (PeproTech, Rocky Hill, NJ), and 10 
ng/ml human rIL-4
  (Peprotech). Half of the medium 
was replaced every




+  cells) were collected after 6 days. The 
purity of the DC was >95% as determined by the 
expression of CD14, CD11c and HLA-DR.  
 
Self DNA Preparation. DNA was isolated from the 
blood of aged and young subjects using Qiamp DNA 
Blood Midi Kit from Qiagen (Valencia, CA). RNase 
was added to remove any contaminating RNA. Purity 
and yield of DNA was measured by UV 
spectrophotometer. Preparations with 260/280 ratio 
above 1.9 were used in all experiments. DNA obtained 
was free of endotoxin contamination as determined by 
Limulus amoebocyte
  lysate (LAL) assay (Lonza Inc, 
Allendale, NJ). 
 
DC activation. Transfection reagent Lipofectamine 
2000 (Invitrogen, Carlsbad, CA) was used to deliver 
self DNA to DCs. DNA was mixed with lipofectamine 
(lipo) in 100 μl of Opti-MEM for 20 minutes at room 
temperature, according to the protocol recommended by 
the manufacturer and added to 4×10
5 DCs in 300 μl of 
complete medium. Final concentration of the DNA was 
1μg/ml. Cell viability was unaffected by this treatment. 
Unstimulated and Lipofectamine-stimulated DCs were 
used as controls. After 24 hours, cells were harvested 
and stained for surface markers CD80, CD86 and 
CD83, using directly conjugated antibodies and isotype 




+ cells per condition were acquired 
using a FACSCalibur (BD
  Pharmingen, San Jose, 
California).  Analysis was performed using the Flow jo 
software (Treestar Inc, Ashland, OR).
  
Cytokine, IFN-α  in the supernatants was measured by 
verikine IFN-α measuring kit (PBL Biomedicals, 
Piscatway, NJ) as per the manufacturer’s protocol.  
 
Quantification of DNA methylation. Global methylation 
of DNA from aged and young subjects was determined 
using the Methylamp™ Global DNA Methylation 
Quantification Kit from Epigentek (Brooklyn, NY), as 
per the manufacturer’s protocol. In this kit the 
methylated fraction of DNA is recognized by 5-
methylcytosine antibody and quantified through an 
ELISA-like reaction. 
 
Methylation of DNA. 1μg of DNA was methylated in 
GC Reaction Buffer containing 60 units of GpC 
Methyltransferase (M.CviPI) and 160 μM S-
adenosylmethionine from New England Biolabs 
(Ipswich, MA) at 37
oC for either 4 or 18 hours.  The GC 
Methyltransferase methylates all cytosine residues 
within the double stranded recognition sequence of 
5’..GC..3’. Percent methylation was determined using 
the global DNA methylation kit.  
 
Induction of DNA damage. PBMCs from young donors 
were treated with 10uM hydrogen peroxide for 1 h at 
37
oC. DNA was extracted as described from both 
treated and untreated PBMCs. Damage was assessed 
using the DNA damage quantification kit. 
 
Quantification of DNA damage. DNA damage from 
aged and young subjects was quantified using DNA 
damage Quantification kit from BioVision (Mountain 
View, CA) following the manufacturer’s protocol. This 
kit determines the number of abasic sites in purified 
DNA samples utilizes the ARP (Aldehyde Reactive 
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group, which is the open ring form of the 
Apurinic/apyrimidinic (AP) sites. 
 
Statistics. Statistical analysis was performed using 
GraphPad Prism™ 4.00 software (GraphPad Software, 
San Diego, USA). Unpaired data were analyzed with 
the Mann-Whitney test. Wilcoxon signed ranked test 
was used for paired analyses. Statistical significance 
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